My doctor’s office called the insurance company this morning and as a result the insurance company said I’m now approved for Remicade. I was very pleased to hear that.
My doctor’s office said they’ll schedule the first infusion once they have the approval in writing.
I’m still waiting for the insurance company to decide whether they’ll pay for me to go on Remicade.
The medical review unit’s most recent update to my file seems to indicate they think I have Rheumatoid Arthritis. Can it be possible that they don’t know my diagnosis???
On Wednesday they added a note to my file that they’re unable to complete the review until they know whether I’m either on Methotrexate or can’t tolerate it. This is what their Remicade policy says about Crohn’s and RA: Continue reading »
Ben turned 15 this week. One of the presents he asked for was a Rubik’s cube. He didn’t go to bed until he’d figured out (with some help) how to solve it. It’s gone to school with him a couple of times since then.
Steve is mentioned in this press release by his company
“Insurance company stocks show a strong positive relationship between their prospective return on equity and price-to-book multiple,” said Stephen Mildenhall, executive vice president and chief actuary at Aon Re Services. “This relationship is far steeper for a company that has produced a stable stream of earnings than for one which has had one or more earnings hits. Our study clearly shows the value in effective enterprise risk management and risk transfer programs.”
Steve works for a reinsurance broker. This press release says that companies with less volatile earnings are worth more. And the way to make earnings less volatile is to buy reinsurance (of course!)
Recent Comments